» Articles » PMID: 22258490

The Risk of Comorbidity

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2012 Jan 20
PMID 22258490
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Impact of an Electronic Best Practice Advisory on Patients' Physical Activity and Cardiovascular Risk Profile.

McCarthy M, Szerencsy A, Fletcher J, Taza-Rocano L, Weintraub H, Hopkins S J Cardiovasc Nurs. 2023; 39(5):E150-E157.

PMID: 37467192 PMC: 10787798. DOI: 10.1097/JCN.0000000000001021.


Incidence and prevalence of Tourette syndrome and chronic tic disorders in Taiwan: a nationwide population-based study.

Chou I, Hung P, Lin J, Hsieh M, Wang Y, Kuo C Soc Psychiatry Psychiatr Epidemiol. 2022; 57(8):1711-1721.

PMID: 35467133 DOI: 10.1007/s00127-022-02253-7.


Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016.

Lin M, Yang H, Yen C, Wu C, Jenq C, Kuo G J Clin Med. 2020; 9(11).

PMID: 33172034 PMC: 7694655. DOI: 10.3390/jcm9113578.


Infectious complications associated with parenteral nutrition in intensive care unit and non-intensive care unit patients.

Comerlato P, Stefani J, Viana M, Viana L Braz J Infect Dis. 2020; 24(2):137-143.

PMID: 32205124 PMC: 9392027. DOI: 10.1016/j.bjid.2020.02.002.


Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia.

Wang C, Pusic I, Anadkat M JAMA Dermatol. 2019; 155(7):826-832.

PMID: 30969325 PMC: 6583862. DOI: 10.1001/jamadermatol.2019.0052.


References
1.
Tang J, Wan J, Bailey J . Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population. Stroke. 2008; 39(7):1938-44. DOI: 10.1161/STROKEAHA.107.504688. View

2.
Turesson C, McClelland R, Christianson T, Matteson E . Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2006; 66(1):70-5. PMC: 1798415. DOI: 10.1136/ard.2006.052506. View

3.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

4.
Chaudhry S, Jin L, Meltzer D . Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care. 2005; 43(6):607-15. DOI: 10.1097/01.mlr.0000163658.65008.ec. View

5.
Jonsen A, Clarke A, Joseph L, Belisle P, Bernatsky S, Nived O . Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011; 63(9):1233-7. DOI: 10.1002/acr.20506. View